Early preclinical studies in rodent models of stroke implicated SGLT, based on experiments with the non-selective agent, phlorizin [8,49,50], which has a selectivity ratio of 1.5:1 for SGLT2 over SGLT1 [51]. This evidence concerns the gene SLC5A2 and stroke disorder.